首页> 外文OA文献 >Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

【2h】

Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

机译：服用直接释放窦房结抑制剂的zatebradine对服用缓释硝苯地平的心绞痛患者没有更大的运动耐受性益处：多中心，随机，双盲，安慰剂对照，平行组研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Journal of the American College of Cardiology 26 (1995) 305-312. doi:10.1016/0735-1097(95)80000-7

机译：美国心脏病学会杂志26（1995）305-312。 doi：10.1016 / 0735-1097（95）80000-7

著录项

作者
Divisions of Cardiology, Departments of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA ( host institution ); Frishman, William H. ( author ); Pepine, Carl J. ( author ); Weiss, Robert J. ( author ); Baiker, Wolfgang M. ( author );
展开▼
作者单位

展开▼
年度 1995
总页数
原文格式 PDF
正文语种 English
中图分类

相似文献

外文文献
中文文献

1. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension. [J] . Puig JG, Schunkert H, Taylor A Clinical therapeutics . 2009 ,第12期

机译：在为期1或2期原发性高血压的成年患者进行的为期8周，多中心，随机，双盲，平行组，安慰剂对照的研究中，评估了直接肾素抑制剂阿利吉仑的剂量反应关系。
2. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension. [J] . Puig JG, Schunkert H, Taylor A Clinical therapeutics . 2009 ,第12期

机译：Aliskiren，直接肾素抑制剂，在8周，多中心，随机，双盲，平行组，成年患者阶段1或2个必需高血压患者中的安慰剂对照研究的评价。
3. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension. [J] . Puig JG, Schunkert H, Taylor A Clinical therapeutics . 2009 ,第12期

机译：Aliskiren，直接肾素抑制剂，在8周，多中心，随机，双盲，平行组，成年患者阶段1或2个必需高血压患者中的安慰剂对照研究的评价。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg Administered 3 to 7 Nights Per Week for 24 Weeks in Patients With Chronic Primary Insomnia: A 6-Month Randomized Double-Blind Placebo-Controlled Parallel-Group Multicenter Study [O] . Andrew D. Krystal, Milton Erman, Gary K. Zammit, 2008

机译：慢性原发性失眠患者唑吡坦缓释剂12.5 mg每周3-7晚每周24周的长期疗效和安全性：6个月随机双盲安慰剂对照平行组多中心研究
6. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study [O] . Divisions of Cardiology, Departments of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA ( host institution ), Frishman, William H., Pepine, Carl J., 1995

机译：服用直接释放窦房结抑制剂的zatebradine对服用缓释硝苯地平的心绞痛患者没有更大的运动耐受性益处：多中心，随机，双盲，安慰剂对照，平行组研究的结果

Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

摘要

著录项

相似文献

相关主题

期刊订阅